ECSP22018842A - Concentrado y aislado de cannabinoide, método para su obtención y uso - Google Patents

Concentrado y aislado de cannabinoide, método para su obtención y uso

Info

Publication number
ECSP22018842A
ECSP22018842A ECSENADI202218842A ECDI202218842A ECSP22018842A EC SP22018842 A ECSP22018842 A EC SP22018842A EC SENADI202218842 A ECSENADI202218842 A EC SENADI202218842A EC DI202218842 A ECDI202218842 A EC DI202218842A EC SP22018842 A ECSP22018842 A EC SP22018842A
Authority
EC
Ecuador
Prior art keywords
obtaining
concentrated
isolated cannabinoid
cannabinoid
isolated
Prior art date
Application number
ECSENADI202218842A
Other languages
English (en)
Inventor
Del Greco Lorenzo Venturini
Del Greco Giovanni Venturini
Deborha Decorti
Original Assignee
Herbolea Biotech S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herbolea Biotech S P A filed Critical Herbolea Biotech S P A
Publication of ECSP22018842A publication Critical patent/ECSP22018842A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
    • B01D3/10—Vacuum distillation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se relaciona con un concentrado y aislado de cannabinoide con un alto contenido de formas ácidas de los cannabinoides, método de obtención del mismo y su uso que comprende proporcionar un extracto de lípido usando entre otras cosas parafina y someterla a destilación específica
ECSENADI202218842A 2019-08-27 2022-03-11 Concentrado y aislado de cannabinoide, método para su obtención y uso ECSP22018842A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2019/072843 WO2021037343A1 (en) 2019-08-27 2019-08-27 Cannabinoid concentrate and isolate, method of obtaining the same and use thereof

Publications (1)

Publication Number Publication Date
ECSP22018842A true ECSP22018842A (es) 2022-05-31

Family

ID=67999599

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202218842A ECSP22018842A (es) 2019-08-27 2022-03-11 Concentrado y aislado de cannabinoide, método para su obtención y uso

Country Status (15)

Country Link
US (1) US20220401405A1 (es)
EP (1) EP4022077A1 (es)
CN (1) CN114761572B (es)
AR (1) AR116672A1 (es)
AU (1) AU2019463310B2 (es)
BR (1) BR112022003557A2 (es)
CA (1) CA3149047A1 (es)
CO (1) CO2022003480A2 (es)
EC (1) ECSP22018842A (es)
IL (1) IL290751A (es)
MX (1) MX2022002475A (es)
PE (1) PE20221403A1 (es)
UY (1) UY38385A (es)
WO (1) WO2021037343A1 (es)
ZA (1) ZA202203193B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR123432A1 (es) * 2020-09-04 2022-11-30 Herbolea Biotech S R L Concentrado de cannabinoides libre de thc, método de obtención del mismo y su uso
EP4431169A1 (en) 2023-03-17 2024-09-18 Siegfried AG Method of purifying cannabinoid components from plant extracts
CN116585371A (zh) * 2023-03-22 2023-08-15 晨光生物科技集团股份有限公司 大麻浸膏、其制备方法及其在制备大麻二酚中的应用
IT202400004138A1 (it) * 2024-02-27 2025-08-27 Herbolea Biotech S P A Frazione di oli essenziali, metodo per ottenerla e suoi usi

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403126B1 (en) 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
GB2393182B (en) 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
GB2514054A (en) * 2011-09-29 2014-11-12 Gw Pharma Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
GB2536150A (en) * 2013-11-11 2016-09-07 The Werc Shop Llc Solvent-free processing, system and methods
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
WO2016004410A1 (en) 2014-07-02 2016-01-07 Cannavest Corp. Novel process for generating hemp oil with a high cannabidiol (cbd) content
BR122021018502B1 (pt) * 2014-10-21 2022-05-03 United Cannabis Corp Formulação de canabinoide líquida
US10207198B2 (en) * 2015-01-22 2019-02-19 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
DK3247371T3 (da) * 2015-01-22 2020-06-15 Phytoplant Res S L Fremgangsmåder til oprensning af cannabinoider, sammensætninger og kits dertil
PL3274321T3 (pl) 2015-03-23 2020-03-31 Echo Pharmaceuticals B.V. Izolat kannabidiolu z konopi przemysłowych i jego zastosowanie w preparatach farmaceutycznych i/lub kosmetycznych
GB2541191A (en) 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
EP3150264A1 (de) * 2015-09-30 2017-04-05 Bionorica Ethics GmbH Vakuumdestillation zur anreicherung von cbd
IL248150B (en) * 2016-09-29 2018-05-31 Garti Nissim Method for selective extraction of cannabinoids from a plant source
CN110382704A (zh) * 2017-01-14 2019-10-25 赫博利生物科技有限责任公司 植物大麻素和萜烯的酶辅助的基于脂质的提取和稳定及其获得的产品
US10888595B2 (en) * 2017-04-18 2021-01-12 Jose Rivas Apparatus for preparation of pharmacologically-relevant compounds from botanical sources
US11759724B2 (en) * 2017-04-18 2023-09-19 Jose Rivas Method and apparatus for preparation of pharmacologically-relevant compounds from botanical sources
US10828341B2 (en) * 2017-04-18 2020-11-10 Jose Rivas Method for preparation of pharmacologically-relevant compounds from botanical sources
CN107095302A (zh) * 2017-05-09 2017-08-29 何宗迅 大麻素类混合物及其在食品工业中的应用
US10189762B1 (en) * 2017-07-07 2019-01-29 Orochem Technologies, Inc. Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
GB2564459B (en) 2017-07-12 2022-03-09 Gw Res Ltd Use of cannabinoids in the treatment of a neurodegenerative disease or disorder
EP3461545A1 (de) * 2017-09-30 2019-04-03 Bionorica Ethics GmbH Kurzwegdestillation im vakuum zur anreicherung von naturstoffen
CA3089994A1 (en) * 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
WO2020028991A1 (en) * 2018-08-08 2020-02-13 Neptune Wellness Solutions Inc. Cold extraction method for cannabinoids and terpenes from cannabis by polyunsaturated lipid-based solvents

Also Published As

Publication number Publication date
AU2019463310B2 (en) 2026-04-23
MX2022002475A (es) 2022-03-22
UY38385A (es) 2021-01-29
CO2022003480A2 (es) 2022-05-31
ZA202203193B (en) 2023-09-27
IL290751A (en) 2022-07-01
EP4022077A1 (en) 2022-07-06
CN114761572B (zh) 2024-07-12
CA3149047A1 (en) 2021-03-04
BR112022003557A2 (pt) 2022-05-24
WO2021037343A1 (en) 2021-03-04
AU2019463310A1 (en) 2022-04-07
CN114761572A (zh) 2022-07-15
AR116672A1 (es) 2021-06-02
US20220401405A1 (en) 2022-12-22
PE20221403A1 (es) 2022-09-15

Similar Documents

Publication Publication Date Title
ECSP22018842A (es) Concentrado y aislado de cannabinoide, método para su obtención y uso
ECSP21090414A (es) Anticuerpos multiespecíficos de cadena pesada que se unen a cd22 y cd3
CL2021000432A1 (es) Aparatos de marco aislable y aislante y métodos de fabricación y uso de los mismos
MX2018016411A (es) Resinas de cannabis descarboxiladas, usos de las mismas y metodos para elaborarlas.
CL2019002897A1 (es) Tratamiento para el asma con anticuerpo anti-tslp.
CL2021000028A1 (es) Anticuerpo multiespecifico (divisional de solicitud 937-2020).
CO2019003154A2 (es) Anticuerpos anti-pd-1 y sus usos
MX2021012205A (es) Anticuerpos de cadena pesada que se unen al psma.
CR20190150A (es) Formulaciones de anticuerpos inhibidores de masp-2 altamente concentrados, de baja viscosidad, kits, y métodos
MX2018003827A (es) Anticuerpos anti-cd19 humano con alta afinidad.
MX2018005070A (es) Composición para el tratamiento de cáncer con expresión del igf-1r.
MX2021008216A (es) Anticuerpos anti-tigit.
MX2021005479A (es) Plantas de cannabis con un perfil cannabinoides enriquecido para cannabidiol y ¿-9-tetrahidrocannabinol.
EP4047372A3 (en) Lipopolysaccharide-binding protein as biomarker for non-alcoholic fatty liver disease
CL2019002797A1 (es) Preservantes para madera.
CO2021001057A2 (es) Composición y método para el ahorro de opioides
MX2023011454A (es) Reaccion de prins y compuestos utiles en la sintesis de macrolidos de halicondrina y analogos de los mismos.
CL2025002872A1 (es) Anticuerpos anti-cd19 y estructuras car-t
CL2025000063A1 (es) Anticuerpos anti-abeta
CO2019013721A2 (es) Sistemas y método para la preparación de bebidas que contienen etanol
CO2019011271A2 (es) Análogos de deutetrabenazina, su preparación y uso
MX2018001048A (es) Metodo para separar los constituyentes isoprenicos del guayule.
AR109504A1 (es) Mermelada de fruta que comprende alulosa y método para preparar la misma
MX391205B (es) Metodo para producir celulas progenitoras renales.
BR112017014297A2 (pt) método para preparar um concentrado de café, e, concentrado de café.